Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06362161 · ClinicalTrials.gov registry record
Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
A clinical trial of Convulsion, Non-Epileptic and Functional Neurological Disorder, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- 1,100
- Enrollment target
- 1
- Study location
NCT06362161 is a study of Convulsion, Non-Epileptic and Functional Neurological Disorder that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 1,100 participants, above the 97-participant average among 4 other Convulsion, Non-Epileptic trials with a reported enrollment target (1034% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06362161, a study of Convulsion, Non-Epileptic and Functional Neurological Disorder, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- 1,100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to help providers develop an interdisciplinary treatment pathway for functional neurological disorder (FND) at University of Alabama at Birmingham (UAB), and will involve psychiatry, speech therapy, physical therapy, and occupational therapy. The study will also help providers to evaluate the treatment pathway and publish results regarding the process and outcomes.
Conditions Studied
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2025-07-18 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06362161
The ClinicalTrials.gov registry entry for NCT06362161 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 97-participant average among 4 other Convulsion, Non-Epileptic trials with a reported enrollment target (1034% higher). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Convulsion, Non-Epileptic appearing as the primary indexed condition, and to 0 interventions.
NCT06362161 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT06362161 about?
NCT06362161 is a clinical study titled "Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND". The purpose of this study is to help providers develop an interdisciplinary treatment pathway for functional neurological disorder (FND) at University of Alabama at Birmingham (UAB), and will involve psychiatry, speech therapy, physical therapy, and occupational therapy. The study will also help pro...
What is the current status of trial NCT06362161?
This trial is currently recruiting. The enrollment target is 1,100 participants. The study started on 2025-07-18. Estimated completion is 2028-12-31.
What conditions does trial NCT06362161 study?
This clinical trial studies the following conditions: Convulsion, Non-Epileptic, Functional Neurological Disorder, Functional Seizure.
Who is sponsoring clinical trial NCT06362161?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06362161 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Convulsion, Non-Epileptic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Retraining and Control Therapy (ReACT) R33 Phase
RECRUITING · NA
-
Retraining and Control Therapy (ReACT)- Adults
RECRUITING · NA
-
Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES
RECRUITING · NA
-
A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.